We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Korro Bio
KRRO
$193M
| $436K | ﹤0.01% |
875
+261
| +43% | +$127K |
|
|
NESR
2627
National Energy Services Reunited Corp
NESR
$2.94B
| $436K | ﹤0.01% |
30,615
+6,310
| +26% | +$84.8K |
|
|
FUV
2628
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $436K | ﹤0.01% |
+1,268
| New | +$293K |
|
2629
First Bancorp
FNLC
$396M
| $435K | ﹤0.01% |
14,780
-2,110
| -12% | -$63K |
|
|
KALV
2630
DELISTED
KalVista Pharmaceuticals
KALV
| $435K | ﹤0.01% |
18,164
-5,013
| -22% | -$131K |
|
2631
SmartFinancial
SMBK
$889M
| $435K | ﹤0.01% |
18,124
-3,065
| -14% | -$72.1K |
|
2632
Peoples Financial Services
PFIS
$705M
| $434K | ﹤0.01% |
10,183
-1,066
| -9% | -$45.8K |
|
|
GOCO
2633
DELISTED
GoHealth
GOCO
| $432K | ﹤0.01% |
2,566
+226
| +10% | +$39.6K |
|
2634
Forestar Group
FOR
$1.51B
| $430K | ﹤0.01% |
20,560
-4,572
| -18% | -$107K |
|
2635
Q32 Bio
QTTB
$471M
| $430K | ﹤0.01% |
3,287
+1,215
| +59% | +$152K |
|
|
FCBP
2636
DELISTED
First Choice Bancorp Common Stock
FCBP
| $430K | ﹤0.01% |
14,114
-1,646
| -10% | -$49K |
|
2637
Home Bancorp
HBCP
$567M
| $427K | ﹤0.01% |
11,200
-1,554
| -12% | -$59.4K |
|
|
GOLD
2638
Gold.com Inc
GOLD
$1.26B
| $426K | ﹤0.01% |
+18,344
| New | +$410K |
|
2639
Allient
ALNT
$1.89B
| $425K | ﹤0.01% |
12,322
-977
| -7% | -$34.4K |
|
|
RJET
2640
Republic Airways Holdings
RJET
$994M
| $422K | ﹤0.01% |
3,014
+232
| +8% | +$37.4K |
|
|
EGLE
2641
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $422K | ﹤0.01% |
8,917
+1,730
| +24% | +$78.4K |
|
2642
BioXcel Therapeutics
BTAI
$27.9M
| $421K | ﹤0.01% |
906
+58
| +7% | +$31.6K |
|
2643
Cadiz
CDZI
$291M
| $419K | ﹤0.01% |
30,804
+452
| +1% | +$5.41K |
|
|
CSSE
2644
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
| $419K | ﹤0.01% |
+10,128
| New | +$356K |
|
|
FLXN
2645
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $419K | ﹤0.01% |
50,940
-2,932
| -5% | -$24.9K |
|
2646
BlueLinx
BXC
$708M
| $417K | ﹤0.01% |
+8,297
| New | +$408K |
|
2647
Lindblad Expeditions
LIND
$2.21B
| $416K | ﹤0.01% |
26,007
-787
| -3% | -$13.3K |
|
2648
Altimmune
ALT
$595M
| $415K | ﹤0.01% |
+42,161
| New | +$577K |
|
2649
Utah Medical Products
UTMD
$223M
| $414K | ﹤0.01% |
4,871
+411
| +9% | +$35.6K |
|
|
LONA
2650
LeonaBio Inc
LONA
$70.8M
| $412K | ﹤0.01% |
4,026
+2,849
| +242% | +$497K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.